Advanced Engineering Materials, EarlyView.Scandium (Sc)‐doped AlCoCrFeMo HEA coatings are fabricated via flame spraying with 0.1, 0.3, and 0.5 wt% Sc additions. Among these, the HEA‐Sc0.3 coating exhibits the highest corrosion resistance, indicated by a more positive corrosion potential and lower current density.
Pankaj Kumar +7 more
wiley +1 more source
SARS outbreak over, but concerns for lab safety remain
Bulletin of the World Health Organization, 2004 Fiona Fleck
doaj
Post-marketing safety concerns with trofinetide: a disproportionality analysis of the first therapeutic agent for Rett syndrome based on the FDA adverse event reporting system (FAERS). [PDF]
Front PharmacolYu X, Zhong J, Lin Z, Fu H, Zhang Y.
europepmc +1 more source
Advanced Engineering Materials, EarlyView.Digitalizing electroplating requires both domain knowledge and interoperability. This work introduces PlatOn, a domain ontology for trivalent chromium plating and coating characterization, and a hybrid pipeline that aligns it to a mid‐level reference ontology by combining eight similarity metrics with language model reasoning. Expert‐validated mappings
Janik Harter +10 more
wiley +1 more source
Longitudinal Descriptive Analysis of Dynamic Changes in Safety Concerns in Japanese Risk Management Plans for Medicinal Products Over 8 Years After Approval. [PDF]
Ther Innov Regul SciIshiguro C, Sazawa M, Nonaka T.
europepmc +1 more source
Action and immunomodulatory mechanisms, formulations, and safety concerns of probiotics. [PDF]
Biosci Microbiota Food HealthAshaolu TJ, Greff B, Varga L.
europepmc +1 more source
Safety Concerns in Neurological Clinical Trials: A Challenge That the FDA Must Resolve. [PDF]
BiomedicinesNiazi SK.
europepmc +1 more source
Post-marketing safety concerns with Tislelizumab: a disproportionality analysis of the FDA adverse event reporting system. [PDF]
Front ImmunolLi C, Ding Y, Cai S, Liu BC, Wang X.
europepmc +1 more source
Post-marketing safety concerns with dolutegravir: a pharmacovigilance study based on the FDA adverse event reporting system database. [PDF]
Front PharmacolSu J, He L, Wang M.
europepmc +1 more source
Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment.
J Clin Endocrinol MetabHuang J, Su A, Yang J, Zhuang W, Li Z.
europepmc +1 more source